Smart Inhaler Technology Market REPORT OVERVIEW
-
Request a Free Sample to learn more about this report
The Smart Inhaler Technology Market size is expected to grow USD 88 Million in 2022 to USD 1555.35 Million by 2031 at a Compound Annual Growth (CAGR) of 37.6% from 2022 to 2031.
Smart inhalers are devices that use Bluetooth to link to a mobile application in order to manage chronic respiratory illnesses and improve patient lifestyle. The increased frequency of respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disorders, among others, has resulted in an exponential increase in demand for smart inhalers. Smart inhalers are an improvement over traditional inhalers. These involve the use of linking technology and sensors, through which the general system collects and saves information about the patient's routines and needs. This connectivity technology assists in advising patients of the need to replenish inhalers and when to take medication, even changing the dosage according on the patient's condition.
COVID-19 Impact: Lockdown Gave Rise to Tremendous Blow Up in the Market Growth
The pandemic is expected to have a beneficial impact on the growth of the smart inhaler technology industry. Now available technological capabilities include recording when an inhaler was used, reminding patients of their next dose, technique analysis by monitoring of inspiratory flow rate, and feedback on technique and timing of inhaler usage. The data collected by these devices can also be securely sent to a healthcare practitioner to provide a "real world" view on each patient's adherence and competency to medication. Hospital and clinic visits increased dramatically as a result of epidemic chronic diseases, including COVID-19, and consequently demand for inhalers and nebulizers fueled market expansion.
LATEST TRENDS
"Development in Vegetarian and Halal Products to Attract the Consumers and Expand the Market"
The smart inhaler technology sector has been seeing rapid growth in recent years and is expected to continue in the next years. Since changing traditional medical protocols and increasing IoT penetration in the healthcare and medical device sectors, smart inhalers can address the challenges of patients and healthcare professionals in the administration of these diseases by using digital features aimed at interacting with mobile applications for monitoring medication routines and subsequent dosing. They can also notify patients and professionals when symptoms necessitate specific action and support a change to improved self-care.
The advancement in medical technology, as well as the necessity to manage the rising treatment costs associated with respiratory ailments, are driving the growth of the smart inhaler technology market. Nothing costs less than a few lacs, from medications to operations to other medical procedures. Smart inhalers are seen as a promising innovation since they track drug adherence based on the type of respiratory ailment. As a result, the patient's outcome is improved and treatment expenses are reduced. This, combined with recent advancements in smart inhaler technology, which allows users to receive feedback on their inhaler technique and calculate the optimum degree of adherence, is propelling the industry.
Smart Inhaler Technology Market SEGMENTATION
-
Request a Free Sample to learn more about this report
- By Type
Based on type, the smart inhaler technology market is classified into inhalers, nebulizers and others.
- By Application
Based on application, the smart inhaler technology market is classified into hospitals, clinics and others.
DRIVING FACTORS
"Increasing Pollution and Surge in Respiratory Diseases to Power Up the Market Production"
The growing geriatric population, combined with an increase in respiratory disease rates, is driving the global rise of smart inhalers. The most common uses for smart inhalers are in asthma, which is on the rise due to increased air pollution and the growing number of smokers. Furthermore, the increased adoption of bad habits like as alcohol drinking and smoking, which lead to pulmonary illnesses, has increased the market size for smart inhalers.
"Rising Air Pollution Paving a Path for Pulmonary Diseases to Multiply the Market Demand"
Because of the alarming increase in air pollution and the pulmonary disorders caused by it. For example, air pollution kills an estimated 7 million people worldwide each year as a result of exposure to fine particles in polluted air, which cause diseases such as stroke, heart disease, lung cancer, chronic obstructive pulmonary disease, and respiratory infections such as pneumonia. One of the significant smart inhaler technology market trends is the increasing exposure to air pollution and tobacco smoking.
Rising prevalence of COPD and asthma, an increase in population vulnerable to indoor air pollutants, an increase in air pollution, an increase in alliances between Pharma and digital health companies, and an increase in respiratory diseases are among the key factors, among others, accelerating market growth. The global rise in pollution levels, which has led to an increase in the population susceptible to chronic obstructive pulmonary diseases, also plays a critical role in escalating market growth.
RESTRAINING FACTORS
"The High Cost Over the Traditional Inhalers to Impede the Market Growth"
Market constraints include a lack of awareness and the overall high cost of inhalers. Furthermore, concerns about data misuse and data privacy are impeding the growth of this market all over the world. Some constraints, such as the high cost of smart inhalers and the availability of extra manual inhalers, may, nevertheless, provide a minor impediment to the development of the smart inhaler technology market share.
Smart Inhaler Technology Market REGIONAL INSIGHTS
-
Request a Free Sample to learn more about this report
"North America to Lead the Market with the Rapid Growth and Potential Manufacturers"
With approximately a quarter of the global market share for smart inhaler technology, the North American region is recognized as having the fastest expanding market. North America dominated the smart inhaler technology market in 2019, and the region will provide market vendors with several growth prospects during the forecast period. The increasing awareness of the use of smart inhalers and connected healthcare systems, as well as the growing use of smart inhalers, will considerably boost the market growth in this region over the forecast period. North America will account for 40% of market growth throughout the projection period. The United States is a crucial market for smart inhaler technology in North America.
KEY INDUSTRY PLAYERS
"Notable Players to contribute towards the market growth"
The top notch players of the market share are implementing and applying varied front end and back end strategies to exceed and expand their empire.
List of Market Players Profiled
- 3M (Canada)
- Abbott Laboratories (U.S.A)
- Propeller Health (U.S.A)
- Teva Pharmaceuticals (Israel)
- Adherium (Australia)
- Cohero Health (U.S.A).
REPORT COVERAGE
The report covers the information on the advancement outlooks with new inventions and SWOT analysis.The market elements situation, with the development areas of the market in the upcoming years. Market segmentation information including the subjective and quantitative research including the effect of financial and strategy viewpoints are discussed in the report. The report also disseminates the information on the regional and nation level assessment incorporating the demand and supply dominators that are affecting the development of the market. The competitive landscape including market share of major players, along with the new research methodologies and strategies adopted by players for the forecasted period is listed in the report.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 88 Million in 2022 |
Market Size Value By |
US$ 1555.35 Million by 2031 |
Growth Rate |
CAGR of 37.6% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the Smart Inhaler Technology Market expected to touch by 2031?
The global smart inhaler technology market is expected to reach USD 1555.35 million by 2031.
-
What CAGR is the Smart Inhaler Technology Market expected to exhibit by 2031?
The smart inhaler technology market is expected to exhibit a CAGR of 37.6% by 2031
-
Which are the driving factors of the Smart Inhaler Technology Market?
Increasing air pollution and surge in respiratory diseases and rising air pollution paving a path for pulmonary diseases drives the Smart Inhaler Technology Market growth.
-
Which are the top companies operating in the Smart Inhaler Technology Market?
3M, Abbott Laboratories, Propeller Health, Teva Pharmaceuticals, Adherium, Cohero Health and others.